These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21573446)

  • 1. P53 tumor-suppressor gene and cyclic adenosine-monophosphate in breast and esophageal cancer are regulated through high-concentration of epidermal growth-factor.
    Murayama Y
    Int J Oncol; 1993 Nov; 3(5):873-9. PubMed ID: 21573446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-concentration of epidermal growth-factor induces apoptosis in breast and esophageal cancer-cells transplanted into nude-mice.
    Murayama Y
    Oncol Rep; 1994 Nov; 1(6):1055-62. PubMed ID: 21607490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice.
    Murayama Y
    Ann Surg; 1990 Mar; 211(3):263-8. PubMed ID: 2155590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.
    Fang L; Li G; Liu G; Lee SW; Aaronson SA
    EMBO J; 2001 Apr; 20(8):1931-9. PubMed ID: 11296226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tpl-2 kinase downregulates the activity of p53 and enhances signaling pathways leading to activation of activator protein 1 induced by EGF.
    Khanal P; Lee KY; Kang KW; Kang BS; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):682-9. PubMed ID: 19221002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL; Fu R; Banko M
    Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
    Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
    Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides to p53 tumor suppressor suppress the induction of apoptosis by epidermal growth factor in NCI-H 596 human lung cancer cells.
    Murayama Y; Horiuchi S
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):109-14. PubMed ID: 9149846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of epidermal growth factor on MDA-MB-468 breast cancer cells: alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1.
    Thomas T; Balabhadrapathruni S; Gardner CR; Hong J; Faaland CA; Thomas TJ
    J Cell Physiol; 1999 Jun; 179(3):257-66. PubMed ID: 10228944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor suppresses the tumor growth of human breast cancer transplanted in nude mice.
    Murayama Y; Mishima Y
    Cancer Detect Prev; 1991; 15(2):161-4. PubMed ID: 2032259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.
    Dixit M; Yang JL; Poirier MC; Price JO; Andrews PA; Arteaga CL
    J Natl Cancer Inst; 1997 Mar; 89(5):365-73. PubMed ID: 9060958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A.
    Li HY; Li Y; Yan CH; Li LN; Chen XG
    J Asian Nat Prod Res; 2002 Dec; 4(4):271-80. PubMed ID: 12450255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II.
    Shih A; Zhang S; Cao HJ; Tang HY; Davis FB; Davis PJ; Lin HY
    Endocrinology; 2004 Apr; 145(4):1708-17. PubMed ID: 14691008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
    Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
    Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
    Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.